Literature DB >> 6790016

Hypercalcaemia due to dihydrotachysterol treatment in patients with hypothyroidism after thyroidectomy.

B A Lamberg, M J Tikkanen.   

Abstract

Hypercalcaemia is a recognised complication of hypothyroidism. We describe three patients who developed hypercalcaemia after thyroidectomy when thyroid supplements were discontinued. They were treated with thyroxine, dihydrotachysterol, and calcium after operation, and in all three cases serum calcium concentrations remained constant during combined treatment. Thyroxine treatment was discontinued several weeks before a radioiodine scan was performed; dihydrotachysterol and calcium were continued throughout. Serum calcium concentrations rose to hypercalcaemic levels in all cases. Elimination of dihydrotachysterol from plasma may be delayed in hypothyroidism, resulting in hypervitaminosis D. It is advisable to reduce the dose of dihydrotachysterol and to check serum calcium concentrations regularly in patients whose thyroid treatment is interrupted.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6790016      PMCID: PMC1506235          DOI: 10.1136/bmj.283.6289.461

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  3 in total

1.  Hypercalcemia in myxedema.

Authors:  C E LOWE; E D BIRD; W C THOMAS
Journal:  J Clin Endocrinol Metab       Date:  1962-03       Impact factor: 5.958

2.  The influence of thyroid hormone on calcium absorption from the gut in relation to urinary calcium excretion.

Authors:  J F Lekkerkerker; H Doorenbos
Journal:  Acta Endocrinol (Copenh)       Date:  1973-08

3.  Influence of thyroid function on the serum concentration of 1,25-dihydroxyvitamin D3.

Authors:  R Bouillon; E Muls; P De Moor
Journal:  J Clin Endocrinol Metab       Date:  1980-10       Impact factor: 5.958

  3 in total
  1 in total

Review 1.  Calcium metabolism in thyroid disease.

Authors:  G Benker; N Breuer; R Windeck; D Reinwein
Journal:  J Endocrinol Invest       Date:  1988-01       Impact factor: 4.256

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.